NAYA Biosciences, Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
NAYA Biosciences, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2010 to Q3 2024.
  • NAYA Biosciences, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$301K, a 16.5% increase year-over-year.
  • NAYA Biosciences, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$1.75M, a 113% decline year-over-year.
  • NAYA Biosciences, Inc. annual Nonoperating Income (Expense) for 2023 was -$1.24M, a 371% decline from 2022.
  • NAYA Biosciences, Inc. annual Nonoperating Income (Expense) for 2022 was -$263K, a 81.6% increase from 2021.
  • NAYA Biosciences, Inc. annual Nonoperating Income (Expense) for 2021 was -$1.43M, a 49.4% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$1.75M -$301K +$59.3K +16.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-19
Q2 2024 -$1.81M -$342K -$171K -99.4% Apr 1, 2024 Jun 30, 2024 10-Q/A 2024-11-19
Q1 2024 -$1.64M -$648K -$404K -165% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$1.24M -$463K -$417K -893% Oct 1, 2023 Dec 31, 2023 10-K/A 2024-11-19
Q3 2023 -$823K -$360K -$336K -1388% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-19
Q2 2023 -$487K -$172K -$52.7K -44.4% Apr 1, 2023 Jun 30, 2023 10-Q/A 2024-11-19
Q1 2023 -$434K -$244K -$171K -233% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$263K -$46.7K +$355K +88.4% Oct 1, 2022 Dec 31, 2022 10-K/A 2024-11-19
Q3 2022 -$618K -$24.2K +$183K +88.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$802K -$119K -$188K -271% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$613K -$73.4K +$820K +91.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$1.43M -$402K +$1.62M +80.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-17
Q3 2021 -$3.05M -$208K +$296K +58.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$3.35M $69.4K +$329K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$3.68M -$894K -$846K -1767% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$2.83M -$2.02M -$1.97M -4260% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$858K -$504K -$457K -962% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$402K -$260K -$84.2K -47.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$317K -$47.9K +$61.6K +56.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$379K -$46.3K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-30
Q3 2019 -$47.5K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$176K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$109K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q3 2011 $73.3K -$56.5K -43.5% Jul 1, 2011 Sep 30, 2011 10-Q 2011-11-21
Q2 2011 -$102K -$21.3K -26.3% Apr 1, 2011 Jun 30, 2011 10-Q 2011-08-22
Q3 2010 $130K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-21
Q2 2010 -$81K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.